More
    Guided Solutions - Connecting Talent With Innovation/div>

    Hyperfine prices $17.5M offering

    Hyperfine announced that it priced an underwritten public offering worth approximately $17.5 million in proceeds. Guildford, Connecticut-based Hyperfine’s offering includes 14 million shares of its...

    HistoSonics announces $250M growth financing

    HistoSonics announced that it closed an oversubscribed $250 million financing to support the expansion of its histotripsy platform. Minneapolis-based HistoSonics’ new ownership group — a...

    Smartlens secures $5.2m to advance FDA process and prepare for miLens launch

    Smartlens, a clinical-stage ophthalmic technology company advancing next-generation glaucoma management devices, today announced the closing of an oversubscribed$5.2 million bridge round led by Ambit...

    ABK Biomedical raises $35 million in Series D financing

    ABK Biomedical, Inc., an innovative medical device company dedicated to the research, development, and commercialisation of advanced imageable embolic medical devices, today announced an...

    Neuronoff closes oversubscribed $4.5M round to launch Injectrode platform

    Neuronoff, a clinical-stage medical device company pioneering minimally invasive pain treatments, today announced the closure of an oversubscribed $4.5 million financing round to advance...

    Jupiter Endovascular raises more than $40M in oversubscribed Series B

    Jupiter Endovascular announced today that it closed an oversubscribed Series B financing that surpassed its target of $40 million. Sonder Capital led the financing, while...

    Microbot Medical closes up to $92.2 million in financing

    Microbot Medical exercised certain investment options worth up to $92.2 million. The Hingham, Massachusetts-based surgical robot maker said last month that investors agreed to exercise...

    Askel Healthcare has closed its latest crowdfunding round

    Askel Healthcare, a Finland-based MedTech company set to transform surgical knee cartilage treatment and recovery, announced it closed its latest crowdfunding round. The company shared...

    AtaCor raises $75M to support extravascular defibrillator

    AtaCor Medical entered a financing worth up to $75 million to support its U.S. FDA pivotal study. The study evaluates the company’s parasternal extravascular implantable...

    Latest articles